This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

SFMS Announces Investigation Into Gentiva Health Services’ Acquisition Of Odyssey Healthcare

Shepherd, Finkelman, Miller & Shah, LLP (“SFMS”) ( is investigating the agreement under which Gentiva Health Services (“Gentiva”) (Nasdaq: GTIV) intends to acquire Odyssey Healthcare, Inc. (“Odyssey Healthcare”) (Nasdaq: ODSY). Odyssey Healthcare, based in Dallas, Texas, provides hospice care for patients. Gentiva, with headquarters in Atlanta, Georgia, provides home health services. The agreement, announced on May 24, 2010, would allow Gentiva to acquire Odyssey Healthcare for $27.00 per share, or approximately $1.1 billion for the transaction. SFMS’ investigation of the agreement concerns whether there has been adequate disclosure to shareholders concerning the terms of the acquisition and whether the compensation offered to Odyssey Healthcare shareholders pursuant to the acquisition is adequate. The transaction is expected to be completed in the third quarter of 2010.

If you own shares of Odyssey Healthcare and would like to request additional information about this investigation, please contact Karen M. Leser-Grenon at or toll-free at 866-540-5505 (ext. 206) or Patrick A. Klingman at or toll-free at 866-540-5505 (ext. 205).

Shepherd, Finkelman, Miller & Shah, LLP ( is a law firm that represents consumers, fiduciaries, beneficiaries and investors, including institutions and individuals, in class action and other complex litigation, and maintains offices in California, Connecticut, Florida, New Jersey, Pennsylvania and Wisconsin. The firm’s attorneys have experience prosecuting cases on behalf of shareholders in mergers and acquisitions throughout the United States.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
GTIV $19.19 -1.18%
AAPL $128.78 -0.45%
FB $80.01 0.52%
GOOG $569.61 -0.70%
TSLA $198.33 -0.62%


DOW 18,048.67 -154.70 -0.85%
S&P 500 2,091.66 -16.12 -0.76%
NASDAQ 4,945.8970 -34.0040 -0.68%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs